Beta-2-adrenoreceptor (β2ARs) agonists (β2-agonists) are used primarily as bronchodilators in the therapy of obstructive airways disorders, especially bronchial asthma and chronic obstructive pulmonary disease (COPD) [1, 2]. This evidence concerns the gene ADRB2 and chronic obstructive pulmonary disease.